Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions

Bone

Volumn 38, Issue 2, 2006, Pages 154-166

  Feeley, Brian T ^a   Krenek, Lucie ^a   Liu, Nancy ^a   Hsu, Wellington K ^a   Gamradt, Seth C ^a   Schwarz, Edward M ^b   Huard, Johnny ^c   Lieberman, Jay R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bone morphogenetic proteins; Osteolytic; Prostate cancer

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; NOGGIN; OSTEOGENIC PROTEIN 1; RETROVIRUS VECTOR;

ARTICLE; BONE ATROPHY; CANCER CELL CULTURE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; OSTEOCLAST; OSTEOLYSIS; OSTEOSARCOMA; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIBIA; WESTERN BLOTTING;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; BONE NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; GENE EXPRESSION; HUMANS; MALE; MICE; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; OSTEOCLASTS; OSTEOLYSIS; PROSTATIC NEOPLASMS; RATS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 31544464054     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.07.015     Document Type: Article

References (53)

1. E. Abe, M. Yamamoto, Y. Taguchi, B. Lecka-Czernik, C.A. O'Brien, and A.N. Economides Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin J. Bone Miner. Res. 15 2000 663 673
2. S.F. Arnold, E. Tims, and B.E. McGrath Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2 Cytokine 11 1999 1031 1037
3. T. Baade Ro, R. Utne Holt, A.T. Brenne, H. Hjorth-Hansen, A. Waage, and O. Hjertner Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells Oncogene 23 2004 3024 3032
4. K.D. Brubaker, E. Corey, L.G. Brown, and R.L. Vessella Bone morphogenetic protein signaling in prostate cancer cell lines J. Cell Biochem. 91 2004 151 160
5. L.J. Brunet, J.A. McMahon, A.P. McMahon, and R.M. Harland Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton Science 280 1998 1455 1457
6. S. Buckley, W. Shi, B. Driscoll, A. Ferrario, K. Anderson, and D. Warburton BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells Am. J. Physiol. Lung Cell Mol. Physiol. 286 2004 L81 L86
7. L.M. Childs, J.J. Goater, R.J. O'Keefe, and E. Schwarz Eficacy of etanercept for wear debris-induced osteolysis J. Bone Miner. Res. 16 2001 338 349
8. E. Corey, J.E. Quinn, F. Bladou, L.G. Brown, M.P. Roudier, and J.M. Brown Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells Prostate 52 2002 20 33
9. Y.J. Cui, F., G. Thomas, and J.L. Christian BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development EMBO J. 17 1998 4735 4743
10. L. Gilboa, A. Nohe, T. Geissendorfer, W. Sebald, Y.I. Henis, and P. Knaus Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors Mol. Biol. Cell 11 2000 1023 1035
11. D. Glaves Mechanisms of metastasis: prostate cancer Prog. Clin. Biol. Res. 239 1987 329 345
12. J. Groppe, J. Greenwald, E. Wiater, J. Rodriguez-Leon, A.N. Economides, and W. Kwiatkowski Structural basis of BMP signalling inhibition by the cysteine knot protein Noggin Nature 420 2002 636 642
13. J. Groppe, J. Greenwald, E. Wiater, J. Rodriguez-Leon, A.N. Economides, and W. Kwiatkowski Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membered cysteine knot protein J. Bone Joint Surg. Am. 85-A Suppl 3 2003 52 58
14. D. Hannallah, H. Peng, B. Young, A. Usas, B. Gearhart, and J. Huard Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model J. Bone Joint Surg. Am. 86-A 2004 80 91
15. S.E. Harris, M.A. Harris, P. Mahy, J. Wozney, J.Q. Feng, and G.R. Mundy Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells Prostate 24 1994 204 211
16. H. Ide, T. Yoshida, N. Matsumoto, K. Aoki, Y. Osada, and T. Sugimura Growth regulation of human prostate cancer cells by bone morphogenetic protein-2 Cancer Res. 57 1997 5022 5027
17. M.E. Kaighn, K.S. Narayan, Y. Ohnuki, J.F. Lechner, and L.W. Jones Establishment and characterization of a human prostatic carcinoma cell line (PC-3) Invest. Urol. 17 1979 16 23
18. H. Kaneko, T. Arakawa, H. Mano, T. Kaneda, A. Ogasawara, and M. Nakagawa Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts Bone 27 2000 479 486
19. M. Kawabata, T. Imamura, and K. Miyazono Signal transduction by bone morphogenetic proteins Cytokine Growth Factor Rev. 9 1998 49 61
20. J. Kleeff, H. Maruyama, T. Ishiwata, H. Sawhney, H. Friess, and M.W. Buchler Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo Gastroenterology 116 1999 1202 1216
21. K.S. Koeneman, F. Yeung, and L.W. Chung Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment Prostate 39 1999 246 261
22. M. Koutsilieris, S.A. Rabbani, H.P. Bennett, and D. Goltzman Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype J. Clin. Invest. 80 1987 941 946
23. S.H.M. Landis, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics CA Cancer J. Clin. 28 1998 6 29
24. P.H. Lange, and R.L. Vessella Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone Cancer Metastasis Rev. 17 1998 331 336
25. E.M. Langenfeld, S.E. Calvano, S.F. Lowry, P. Amenta, and J. Langenfeld The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells Carcinogenesis 2003 1445 1454
26. Y. Lee, E. Schwarz, M. Davies, M. Jo, J. Gates, and J. Wu Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone J. Orthop. Res. 21 2003 62 72
27. Y.P. Lee, E.M. Schwarz, M. Davies, M. Jo, J. Gates, and X. Zhang Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model Cancer Res. 62 2002 5564 5570
28. J.R. Lieberman, A. Daluiski, and T.A. Einhorn The role of growth factors in the repair of bone. Biology and clinical applications J. Bone Joint Surg. Am. 84-A 2002 1032 1044
29. F. Liu, F. Ventura, J. Doody, and J. Massague Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs Mol. Cell. Biol. 15 1995 3479 3486
30. J. Massague TGF-beta signal transduction Annu. Rev. Biochem. 67 1998 753 791
31. H. Mayer, A.M. Scutt, and T. Ankenbauer Subtle differences in the mitogenic effects of recombinant human bone morphogenetic proteins-2 to -7 on DNA synthesis on primary bone-forming cells and identification of BMP-2/4 receptor Calcif. Tissue Int. 58 1996 249 255
32. J.A. McMahon, S. Takada, L.B. Zimmerman, C.M. Fan, R.M. Harland, and A.P. McMahon Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite Genes Dev. 12 1998 1438 1452
33. A. Nohe, S. Hassel, M. Ehrlich, F. Neubauer, W. Sebald, and Y.I. Henis The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways J. Biol. Chem. 277 2002 5330 5338
34. H. Peng, S.T. Chen, J.E. Wergedal, J.M. Polo, J.K. Yee, and K.H. Lau Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4 Mol. Ther. 4 2001 95 104
35. H. Peng, V. Wright, A. Usas, B. Gearhart, H.C. Shen, and J. Cummins Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4 J. Clin. Invest. 110 2002 751 759
36. A. Penton, Y. Chen, K. Staehling-Hampton, J.L. Wrana, L. Attisano, and J. Szidonya Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor Cell 78 1994 239 250
37. F. Pouliot, A. Blais, and C. Labrie Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells Cancer Res. 63 2003 277 281
38. C.R. Pound, P.C. Walsh, J.I. Epstein, D.W. Chan, and A.W. Partin Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer World J. Urol. 15 1997 373 377
39. B.L. Rosenzweig, T. Imamura, T. Okadome, G.N. Cox, H. Yamashita, and P. ten Dijke Cloning and characterization of a human type II receptor for bone morphogenetic proteins Proc. Natl. Acad. Sci. U. S. A. 92 1995 7632 7636
40. T. Rothhammer, I. Poser, F. Soncin, F. Bataille, M. Moser, and A.K. Bosserhoff Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration Cancer Res. 65 2005 448 456
41. J.M. Schmitt, K. Hwang, S.R. Winn, and J.O. Hollinger Bone morphogenetic proteins: an update on basic biology and clinical relevance J. Orthop. Res. 17 1999 269 278
42. T.M. Schultheiss, J.B. Burch, and A.B. Lassar A role for bone morphogenetic proteins in the induction of cardiac myogenesis Genes Dev. 11 1997 451 462
43. M. Schwalbe, J. Sanger, R. Eggers, A. Naumann, A. Schmidt, and K. Hoffken Differential expression and regulation of bone morphogenetic protein 7 in breast cancer Int. J. Oncol. 23 2003 89 95
44. I. Sulzbacher, P. Birner, K. Trieb, E. Pichlbauer, and S. Lang The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter J. Clin. Pathol. 55 2002 381 385
45. M. Suzawa, Y. Takeuchi, S. Fukumoto, S. Kato, N. Ueno, and K. Miyazono Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro Endocrinology 140 1999 2125 2133
46. C.M. Tangen, J.R. Faulkner, E.D. Crawford, I.M. Thompson, D. Hirano, and M. Eisenberger Ten-year survival in patients with metastatic prostate cancer Clin. Prostate Cancer 2 2003 41 45
47. P. ten Dijke, J. Fu, P. Schaap, and B.A.J. Roelen Signal transduction of bone morphogenetic proteins in osteoblast differentiation J. Bone Joint Surg. Am. 85-A 2003 33 38
48. P. ten Dijke, H. Yamashita, T.K. Sampath, A.H. Reddi, M. Estevex, and D.L. Riddle Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4 J. Biol. Chem. 269 1994 16985 16988
49. K. Tomari, T. Kumagai, T. Shimizu, and K. Takeda Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells Int. J. Mol. Med. 15 2005 253 258
50. X.Z. Wen, S. Miyake, Y. Akiyama, and Y. Yuasa BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells Biochem. Biophys. Res. Commun. 316 2004 100 106
51. R.N.G. Willette, J.L. Gu, P.G. Lysko, K.M. Anderson, H. Minehart, and T. Yue BMP-2 gene expression and effects on human vascular smooth muscle cells J. Vasc. Res. 36 1999 120 125
52. R.J. Wordinger, R. Agarwal, M. Talati, J. Fuller, W. Lambert, and A.F. Clark Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues Mol. Vis. 8 2002 241 250
53. H. Yonou, A. Ochiai, M. Goya, N. Kanomata, S. Hokama, and M. Morozumi Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions Prostate 58 2004 406 413